Search clinical trials for: FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs,
Total 63992 results
-
Peking UniversityHangzhou DIAN Medical Diagnostic Center Co., Ltd., ChinaRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Gastrointestinal Stromal Tumors | Neuroendocrine Tumors | Esophageal Squamous Cell Carcinoma | Biliary Tract Neoplasms | Unknown Primary Cancer | Digestive CancerChina
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III Melanoma | BRAF Mutant MelanomaUnited States
-
Hunan Cancer HospitalCompletedMetastatic Breast Cancer | Circulating Tumor DNA | Gene Abnormality
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
University Hospital, CaenActive, not recruiting
-
National Cancer Centre, SingaporeTerminated
-
Saint Petersburg State University, RussiaWithdrawnThyroid Gland Anaplastic CarcinomaRussian Federation
-
TriHealth Inc.TriHealth Cancer Institute; TriHealth Surgical Institute; TriHealth Ultrasound... and other collaboratorsWithdrawnMelanoma (Skin) | Tumor Skin | BRAF Gene Mutation | Melanoma Stage IIIb-IVM1a | Metastasis SkinUnited States
-
Vanderbilt-Ingram Cancer CenterAstex Pharmaceuticals, Inc.; Forma Therapeutics, Inc.WithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome
-
University Health Network, TorontoActive, not recruitingSalivary Gland Cancer | Metastatic | Recurrent | AdvancedCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Shanghai Jiao Tong University School of MedicineRecruitingOral Squamous Cell Carcinoma | Anti-PD-1 | Neoadjvant Therapy | Anti-VEGFRChina
-
National Cancer Institute (NCI)Active, not recruitingSoft Tissue Sarcoma | Osteosarcoma | Ewing Sarcoma | Malignant Glioma | Ependymoma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Rhabdomyosarcoma | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma and other conditionsUnited States, Puerto Rico
-
Hellenic Cooperative Oncology GroupActive, not recruitingOvarian CancerGreece
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingThyroid Gland Anaplastic Carcinoma | BRAF V600K Mutation Present | BRAF NP_004324.2:p.V600EUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterCompletedPathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8United States
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
National Cancer Institute (NCI)GlaxoSmithKlineCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingSkin Cancer | Melanoma (Skin) | Skin Carcinoma | Skin MelanomaUnited States
-
CTI BioPharmaTerminatedCOVID-19 | COVID | COVID19United States
-
Ruijin HospitalActive, not recruitingPulmonary Metastases | Osteosarcoma | ApatinibChina
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Metastatic Malignant Solid Neoplasm | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Solid Neoplasm | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma... and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationCompletedMyelodysplastic SyndromesUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science University; American Association for... and other collaboratorsRecruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Ductal Adenocarcinoma | Locally Advanced Pancreatic Ductal Adenocarcinoma | Unresectable Pancreatic Ductal AdenocarcinomaUnited States
-
Allarity TherapeuticsDanish Breast Cancer Cooperative Group; Smerud Medical Research International...Active, not recruiting
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | PARP InhibitorChina
-
Leiden University Medical CenterRadboud University Medical Center; AstraZeneca; University Medical Center Groningen and other collaboratorsActive, not recruitingUterine Neoplasms | Endometrial Neoplasms | Endometrium CancerNetherlands
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingClinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIA Cutaneous Melanoma...United States
-
Sun Yat-sen UniversityHutchmedRecruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer | Ovarian Carcinoma | Fallopian Tube CarcinosarcomaChina
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid LeukemiaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); BeiGeneCompletedRecurrent Glioblastoma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II Glioma | IDH1 Mutation | IDH2 MutationUnited States
-
Samsung Medical CenterRecruitingHeart Failure | Acute Myocardial InfarctionKorea, Republic of
-
Stanford UniversityNovartis PharmaceuticalsCompletedAmeloblastoma | BRAF Gene MutationUnited States
-
Shanghai Henlius BiotechActive, not recruitingAnaplastic Thyroid Cancer | ATCChina
-
Abbisko Therapeutics Co, LtdRecruitingUrothelial CarcinomaChina
-
H. Lee Moffitt Cancer Center and Research InstituteArray BioPharmaCompletedNon-Small Cell Lung Cancer | Lung CancerUnited States
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
Shanghai Henlius BiotechActive, not recruitingLangerhans Cell Histiocytosis | Erdheim-Chester Disease | LCH | ECDChina
-
Shanghai Henlius BiotechActive, not recruitingMetastatic Colorectal Cancer | mCRCChina
-
AstraZenecaCompletedOvarian Neoplasms | BRCA1 Protein | BRCA2 ProteinNetherlands, Belgium, United Kingdom, Poland
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedOvarian NeoplasmUnited States, Spain, Australia, Germany, Sweden
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Taiwan, Korea, Republic of, Singapore
-
Central European Society for Anticancer Drug ResearchUnknownSmall Cell Lung Cancer SCLCGermany
-
Bhavana KondaNational Comprehensive Cancer NetworkActive, not recruitingInsular Thyroid Cancer | Recurrent Thyroid Cancer | Papillary Thyroid Cancer | Follicular Thyroid CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedEndometrial Clear Cell Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Recurrent Uterine Corpus CancerUnited States
-
AstraZenecaCompleted
-
Manisha ShahNational Comprehensive Cancer NetworkCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
The University of Texas Health Science Center at...WithdrawnCancer of the Breast